PEACE OF MIND ACCURACY

UNIQUE FLUORESCENT TECHNOLOGY

• The Eversense® E3 Sensor uses fluorescent light technology to measure glucose in interstitial fluid.
• The intensity of the fluorescent light signal rises and falls in proportion to the body’s glucose levels
• There is no interference with glucose measurements from Vitamin C or acetaminophen.

EXCEPTIONAL ACCURACY—MARD 8.5%

Highly accurate, also in the low glucose range.

• The overall MARD of the Eversense® E3 CGM system is 8.5% with 87.3% of readings within 15 mg/dL or 15% of the reference values (YSI).
• In the hypoglycaemic range (40–60 mg/dL) the MAD* gets even better at 7.5% with 91.6% of readings within 15/15.

STABLE PERFORMANCE UP TO 6 MONTHS

Month by month, Eversense E3 has demonstrated exceptional accuracy and stable performance over the course of 180 days with a single sensor. Readings you can count on!

CONFIRMED HIGH DETECTION RATES

• 94% of low glucose events were detected correctly and alerted (using Predictive Alert), comparing to the laboratory reference (YSI)
• 99% of high glucose events were detected correctly and alerted (using Predictive Alert), comparing to the laboratory reference (YSI)
• Maybe it’s time to consider activating the Predictive Alert feature in the Eversense App. Talk to your health care provider to help you with this setting